10.1038/ncomms1615 - The blood-stage malaria antigen PfRH5...

This document has been corrected

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

10.1038/ncomms1615

Published Online: 2011-12-20

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC

Authors: Adrian V.S. Hill•Alexander D. Douglas•Alison V. Turner•Andrew R. Williams•Anna L. Goodman•Carole A. Long•Cécile Crosnier•David H. Wyllie•Faith H. Osier•Gathoni Kamuyu•Gavin J. Wright•Joseph J. Illingworth•Kazutoyo Miura•Kevin Marsh•Simon J. Draper•Sumi Biswas

This document has been corrected

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

10.1038/ncomms1615

Published Online: 2011-12-20

Journal: Nature Communications

NOW

2013-09-19•Correction

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

10.1038/ncomms3355

* information provided by CrossRef

2013-09-19•Correction

10.1038/ncomms3355

* information provided by CrossRef

2011-12-20•Published

2013-09-19•Correction

Correction: Corrigendum: The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

10.1038/ncomms3355

* information provided by CrossRef

This document has been corrected

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody

10.1038/ncomms1615

Published Online: 2011-12-20

Journal: Nature Communications•Publisher: Springer Science and Business Media LLC